(1) The
administrator of the state health care authority shall, directly
or by contract, adopt policies necessary for establishment of a
prescription drug purchasing consortium. The consortium's
purchasing activities shall be based upon the evidence-based
prescription drug program established under RCW 70.14.050. State
purchased health care programs as defined in RCW 41.05.011 shall
purchase prescription drugs through the consortium for those
prescription drugs that are purchased directly by the state and
those that are purchased through reimbursement of pharmacies,
unless exempted under this section. The administrator shall not
require any supplemental rebate offered to the department of
social and health services by a pharmaceutical manufacturer for
prescription drugs purchased for medical assistance program
clients under chapter 74.09 RCW be extended to any other state
purchased health care program, or to any other individuals or
entities participating in the consortium. The administrator
shall explore joint purchasing opportunities with other states.
(2) Participation in the purchasing consortium shall be
offered as an option beginning January 1, 2006. Participation in
the consortium is purely voluntary for units of local government,
private entities, labor organizations, and for individuals who
lack or are underinsured for prescription drug coverage. The
administrator may set reasonable fees, including enrollment fees,
to cover administrative costs attributable to participation in
the prescription drug consortium.
(3) This section does not apply to state purchased health
care services that are purchased from or through health carriers
as defined in RCW 48.43.005, or group model health maintenance
organizations that are accredited by the national committee for
quality assurance.
(4) The state health care authority is authorized to adopt
rules implementing chapter 129, Laws of 2005.
(5) State purchased health care programs are exempt from the
requirements of this section if they can demonstrate to the
administrator that, as a result of the availability of federal
programs or other purchasing arrangements, their other purchasing
mechanisms will result in greater discounts and aggregate cost
savings than would be realized through participation in the
consortium.
[2009 c 560 § 13; 2005 c 129 § 1.]
NOTES:
Intent -- Effective date -- Disposition of property and funds -- Assignment/delegation of contractual rights or duties -- 2009 c 560: See notes following RCW 18.06.080.
Performance audit -- 2005 c 129 § 1: "By December 1, 2008, the joint legislative audit and review committee shall conduct a performance audit on the operation of the consortium created in section 1 of this act. The audit shall review the operations and outcomes associated with the implementation of this consortium and identify the net savings, if any, to the members of the consortium, the percentage of targeted populations participating, and changes in the health outcomes of participants." [2005 c 129 § 3.]
Severability -- 2005 c 129: "If any provision of this act or its application to any person or circumstance is held invalid, the remainder of the act or the application of the provision to other persons or circumstances is not affected." [2005 c 129 § 4.]
Conflict with federal requirements -- 2005 c 129: "If any part of this act is found to be in conflict with federal requirements that are a prescribed condition to the allocation of federal funds to the state, the conflicting part of this act is inoperative solely to the extent of the conflict and with respect to the agencies directly affected, and this finding does not affect the operation of the remainder of this act in its application to the agencies concerned. Rules adopted under this act must meet federal requirements that are a necessary condition to the receipt of federal funds by the state." [2005 c 129 § 5.]